Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the management of type 2 diabetes. This synthetic peptide resembles the actions of naturally occurring GLP-1, a https://umairpfix116282.life3dblog.com/37727795/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes